http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102330083-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-48 |
| filingDate | 2015-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102330083-B1 |
| titleOfInvention | Pharmaceutical Compositions for Improving or Treating Muscle Atrophy Comprising Conditioned Medium of Stem Cells Derived from Umbilical Cord |
| abstract | The present invention provides a pharmaceutical composition for preventing or treating muscular atrophy comprising a culture solution of mammalian umbilical cord-derived stem cells as an active ingredient. When the umbilical cord-derived stem cell culture solution of the present invention is administered intramuscularly, the administered stem cells are effective for the prevention or treatment of muscular atrophy by proliferating muscle cells at the administered site, increasing muscle mass, and rapidly recovering muscle fatigue. do. Since the present invention uses a stem cell culture medium, it can overcome the technical and practical limitations of the treatment using stem cells, and has the advantage of being relatively easy to secure, so it can be very effectively used for the prevention and treatment of muscular atrophy. |
| priorityDate | 2015-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 248.